Factors of Steroid Dependency in Idiopathic Nephrotic Syndrome
Overview
The primary purpose of the study is to identify the factors of steroid dependency in childhood idiopathic nephrotic syndrome. The steroid dependency is defined by a relapse of nephrotic syndrome within the 3 weeks that follow the withdrawal of steroid therapy after the first manifestation. Different clinical and biological factors will be analyzed: age of first manifestation, delay of remission, ethnicity, and preceding viral infection, geolocalization in the Parisian area, genoprevalence of herpes viruses and polymorphisms in the genes involved in the response to steroid therapy.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Other
- Study Primary Completion Date: June 2016
Detailed Description
Patients with a steroid dependent nephrotic syndrome will be compared to those with a non steroid dependent form of nephrotic syndrome at the end of the first manifestation. An additional blood volume will be sampled in patients and controls during a scheduled biological check-up for the initial disease. Genetics factors will be checked using a DNA chips devoted to the response to steroid therapy and viral genome of EBV, CMV, HHV7 will be searched for using PCR reaction in total blood DNA extract.
Interventions
- Genetic: DNA chip dedicated to the pharmacogenetic of steroids
- direct DNA extraction from peripheral blood cells
Arms, Groups and Cohorts
- children with idiopathic nephrotic syndrome
- children below 16 years of age with a steroid dependent nephrotic syndrome
Clinical Trial Outcome Measures
Primary Measures
- define pharmacogenetic factors of steroid dependency
- Time Frame: 28.5 months
Secondary Measures
- parameters of the immune response against herpesvirus, specially the cellular production of interferon induced by specific viral peptides
- Time Frame: 28.5 months
- Dynamic of the epidemiology of idiopathic nephrotic syndrome in the Paris Area
- Time Frame: 28.5 months
- Number of participants with idiopathic nephrotic syndrome in Paris Area to determinate if clusters cases exist.
- Analysis of cortico-dependence factors
- Time Frame: Day 1
- Comparison of polymorphisms of cortico-dependent patients with non- cortico-dependent patients
- Analysis of susceptibility factors that generate the appearance of the Idiopathic Nephrotic Syndrome
- Time Frame: Day 1
- Comparison of polymorphisms of all patients suffering from the Idiopathic Nephrotic Syndrome, with general population
Participating in This Clinical Trial
Inclusion Criteria
- children below 16 years – first manifestation of nephrotic syndrome – steroid sensitivity according to the recommendations of the french "pediatric society nephrology" Exclusion Criteria:
- patients who don't stay in Paris during the study
Gender Eligibility: All
Minimum Age: 6 Months
Maximum Age: 16 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Assistance Publique – Hôpitaux de Paris
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Georges Deschênes, MD-PhD, Principal Investigator, Assistance Publique
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.